Nordic files patent infringement/false ads suit
This article was originally published in The Tan Sheet
Executive Summary
Watsonville, Calif.-based Nordic Naturals files suit May 4 in the U.S. District Court for the District of Northern California against Arlington Heights, Ill.-based J.R. Carlson Laboratories and San Clemente, Calif.-based Metagenics, alleging lemon-flavored fish oil capsules sold by both companies infringes on two of three method-of-manufacture patents covering its proprietary fruit flavored omega-3 and related softgel capsules. The suit also charges the companies with falsely marketing their products as flavored capsules. Nordic Founder and CEO Joar Opheim told "The Tan Sheet:" "We believe that there was sufficient basis to file suit. We feel that a line has been crossed so we took action to protect our legal rights." The parties are scheduled to meet at the court in August regarding the lawsuit, Opheim said. Carlson and Metagenics have not responded to the suit...
You may also be interested in...
As Casgevy, Lyfgenia Launches Proceed, CRISPR And bluebird bio CEOs Reassure
The CEOs of bluebird bio and CRISPR Therapeutics hope to inspire investor confidence that their gene-based therapies for sickle cell disease and beta thalassemia will be widely reimbursed in the US and EU.
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.